Pedro Coelho Selected Research

Pedro Coelho Research Topics

Disease

7	Neoplasms (Cancer) 02/2022 - 10/2010
6	Melanoma (Melanoma, Malignant) 12/2021 - 10/2010
3	Obesity 12/2021 - 11/2016
2	Cognitive Dysfunction 07/2022 - 01/2022
2	Glioma (Gliomas) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2019
2	Stroke (Strokes) 05/2021 - 07/2017
2	Atrial Fibrillation 05/2021 - 07/2017
1	Atrophy 07/2022
1	Ganglion Cysts (Ganglion) 07/2022
1	Multiple Sclerosis 07/2022
1	Cardiomyopathies (Cardiomyopathy) 05/2021
1	Embolic Stroke 05/2021
1	Patent Foramen Ovale 05/2021
1	Shock 04/2021
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 02/2020
1	Sarcoglycanopathies 02/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Diabetes Mellitus 01/2019
1	Sepsis (Septicemia) 07/2017
1	Allergic Contact Dermatitis 03/2017
1	Dermatitis 03/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Hepatitis C 01/2017
1	Neoplasm Metastasis (Metastasis) 12/2016
1	Hyperplasia 12/2016
1	Skin Neoplasms (Skin Cancer) 11/2016
1	Fetal Alcohol Spectrum Disorders 04/2016
1	Rupture 03/2016
1	Retinal Detachment (Retinal Detachments) 03/2016
1	Iritis 03/2016
1	Bites and Stings (Sting) 06/2015
1	Retinal Arterial Macroaneurysm 05/2015
1	Macular Edema 05/2015
1	Inflammation (Inflammations) 01/2012
1	Breast Neoplasms (Breast Cancer) 10/2010
1	Experimental Melanoma 10/2010
1	Aortic Dissection 10/2003
1	Infarction (Infarctions) 10/2003

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 07/2022 - 05/2015
2	xanthohumolIBA 01/2019 - 01/2012
1	Polysaccharides (Glycans)IBA 02/2022
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	Carrier Proteins (Binding Protein)IBA 02/2022
1	Pharmaceutical PreparationsIBA 02/2022
1	VaccinesIBA 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	Immunoconjugates (Immunoconjugate)IBA 02/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	TabletsIBA 01/2022
1	fibroblast growth factor 21IBA 12/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	Gemcitabine FDA Link 06/2021
1	Docetaxel (Taxotere)FDA Link 06/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	pro-brain natriuretic peptide (1-76)IBA 05/2021
1	Sarcoglycans (beta Sarcoglycan)IBA 02/2020
1	3-nitrotyrosineIBA 01/2020
1	CatalaseIBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Galectin 3 (LGALS3)IBA 01/2019
1	8-prenylnaringeninIBA 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	CreatinineIBA 07/2017
1	AcrylatesIBA 03/2017
1	CryoglobulinsIBA 01/2017
1	Illicit Drugs (Recreational Drugs)IBA 01/2017
1	MetalsIBA 12/2016
1	OxidesIBA 12/2016
1	cafestol palmitateIBA 12/2016
1	kahweol palmitateIBA 12/2016
1	Oxygen (Dioxygen)IBA 11/2016
1	VitaminsIBA 11/2016
1	AntioxidantsIBA 11/2016
1	SeleniumIBA 11/2016
1	Capsules (Microcapsules)IBA 03/2016
1	Conditioned Culture MediaIBA 01/2016
1	VenomsIBA 06/2015
1	Ranibizumab (Lucentis)FDA Link 05/2015
1	PolyphenolsIBA 01/2012
1	Imatinib Mesylate (Gleevec)FDA Link 10/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2010

Therapy/Procedure

3	Therapeutics 02/2022 - 11/2016
2	Radiotherapy 01/2020 - 01/2017
1	Adjuvant Chemoradiotherapy 02/2022
1	Drug Therapy (Chemotherapy) 06/2021
1	Extracorporeal Membrane Oxygenation 04/2021
1	Particle Accelerators 01/2017
1	Intravitreal Injections 05/2015
1	Prostheses and Implants (Prosthesis) 10/2003